Back

Impact of diabetes status and chronic kidney disease on myocardial infarction mortality among elderly patients - a retrospective analysis of data from an ongoing nationwide registry.

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Diabetes and stable coronary artery disease Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Piret Asser

University of Tartu, Tartu (Estonia)

6 More presentations in this session

Presentation thumbnail
Does prediabetes diagnosed by hemoglobinA1c or oral glucose tolerance test predict coronary artery disease in patients suspected of chronic coronary syndrome?
Doctor K. Overgaard (Svendborg, DK)
Abstract Slides Video
Presentation thumbnail
Real-life use of novel glucose lowering agents after acute myocardial infarction and stable coronary artery disease in patients with diabetes - experience from national use in the SWEDEHEART-registry
Doctor V. Ritsinger (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Vessel-oriented cardiovascular events in patients with diabetes undergoing intracoronary physiology-guided revascularization
Doctor S. Sgreva (Galway, IE)
Abstract Slides Video
Presentation thumbnail
Synergistic adverse impact of diabetes and chronic kidney disease on cardiovascular mortality in patients underwent percutaneous coronary intervention
Doctor S. Moriya (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Diabetes mellitus and response to IL-1 blockade with Anakinra after ST-elevation myocardial infarction: a pooled analysis of the VCU-ART studies
Doctor A. Abbate (Charlottesville, US) Doctor F. Moroni (Charlottesville, US)
Abstract Slides Video

Access the full session

Session thumbnail
Diabetes and stable coronary artery disease

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Addressing disparities in the long-term mortality of non-ST segment myocardial infarction (NSTEMI) patients according to the presence of diabetes mellitus: a nationwide cohort study
thumbnail
Congress Presentation
Impact of mildly reduced kidney function on 5-year mortality in patients with STEMI treated with primary PCI
thumbnail
Congress Presentation
Association of quality of care and long-term mortality risk for individuals presenting with ST-segment myocardial infarction (STEMI) by diabetes mellitus status: a nationwide cohort study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources